Skip to main content


We fund game changing ideas and innovations to transform Africa

Funding Opportunities.

4 opportunities available


The AAS is awarding 10 travel grants to research managers and administrators in Africa to attend the INORMS 2020 conference. The conference provides the opportunity to meet, learn and discuss issues of research management and to develop professionally through networking.


The ELA conference targets AAS Fellows, Affiliates, and grantees undertaking research in East and West Africa to provide a platform for sharing lessons in evidence-informed decision making practices across Science, Technology and Innovation (STI) sectors in Africa. The key purpose of the conference is to promote EIDM and contribute to the development of evidence-informed policy, efficient and effective implementation of policies and programmes as well as learning to accelerate the development of all STI sectors in Africa.  


APTI fellows will train in a global health research area of priority for their home institutions and countries, and AAS, BMGF and NIH, while building bridges and lasting connections between the partner organizations and African scientists and institutions.


The ELA initiative invites AAS fellows, affiliates and grantees who are innovating with interventions that promote, support and enable the use of evidence in decision-making in government institutions to apply for a leadership award to recognize these efforts.

Other Funding Opportunities

1 opportunities available

Michelson Prizes

Award value – $150,000

Deadline – 

About the Michelson Prizes
The Michelson Prizes are scientific awards of $150,000 given annually to young investigators who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research across major global diseases.  

The 2020 Michelson Prizes will focus on transformative research in human immunology, with trans-disease applications to accelerate vaccine and immunotherapeutic discovery. The selection committee will be looking to support research that is both highly innovative and has the potential for high impact. Specifically, projects should propose innovative ideas and approaches that can be applied across many disease areas and states. Projects should have the potential to significantly expand our understanding of the human immune system and accelerate the development of vaccines and immunotherapies. 

While the Michelson Prizes are focused on research in the fields of immunology, vaccine and immunotherapy discovery, applicants from the full spectrum of related disciplines, including clinical research, biochemistry, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, biophysics, nanotechnology, etc., are encouraged to apply. 

Pre-applications for the 2020 Michelson Prizes will be accepted from September 9 – October 31, 2019. Applicants selected to submit a full application will be notified in late December 2019. Prizes will be awarded in June 2020 as part of an annual scientific conference on the future of vaccine and immunotherapy development, which brings together top scientists from across disciplines and disease areas.
Additional info can be found at

Link -  Additional info can be found here